ReviewOncoTargets and therapy2018

Efficacy of pemetrexed-based regimens in advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations after tyrosine kinase inhibitor failure: a systematic review.

BaoHui Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.